118 related articles for article (PubMed ID: 12366660)
1. Molecular analysis of inhibin A and activin A subunit gene loci in epithelial ovarian cancer.
Depasquale S; Lambert-Messerlian G; Quddus MR; Campbell I; Steinhoff M; Gajewski W; Granai C; Tantravahi U
Int J Gynecol Cancer; 2002; 12(5):443-7. PubMed ID: 12366660
[TBL] [Abstract][Full Text] [Related]
2. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.
Choi YL; Kim HS; Ahn G
Arch Pathol Lab Med; 2000 Apr; 124(4):563-9. PubMed ID: 10747314
[TBL] [Abstract][Full Text] [Related]
4. Tumor stroma as the main source of inhibin production in ovarian epithelial tumors.
Zheng W; Lu JJ; Luo F; Hsieh J; Wang CY; Zhang C; Chang L; Cho MM; Stanczyk FZ
Am J Reprod Immunol; 2000 Aug; 44(2):104-13. PubMed ID: 10994638
[TBL] [Abstract][Full Text] [Related]
5. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits.
Cobellis L; Cataldi P; Reis FM; De Palo G; Raspagliesi F; Pilotti S; Arcuri F; Petraglia F
Eur J Endocrinol; 2001 Dec; 145(6):779-84. PubMed ID: 11720904
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
7. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BMP4 and BMP7 increase activin A production by up-regulating inhibin βA subunit and furin expression in human granulosa-lutein cells.
Chang HM; Cheng JC; Klausen C; Leung PC
J Clin Endocrinol Metab; 2015 Mar; 100(3):E375-86. PubMed ID: 25562508
[TBL] [Abstract][Full Text] [Related]
9. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
10. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
11. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
13. Activin, inhibin and the human breast.
Reis FM; Luisi S; Carneiro MM; Cobellis L; Federico M; Camargos AF; Petraglia F
Mol Cell Endocrinol; 2004 Oct; 225(1-2):77-82. PubMed ID: 15451571
[TBL] [Abstract][Full Text] [Related]
14. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
15. Cyclic changes in messenger RNAs encoding inhibin/activin subunits in the ovary of the golden hamster (Mesocricetus auratus).
Arai KY; Kishi H; Onodera S; Jin W; Watanabe G; Suzuki AK; Takahashi S; Kamada T; Nishiyama T; Taya K
J Endocrinol; 2005 Jun; 185(3):561-75. PubMed ID: 15930182
[TBL] [Abstract][Full Text] [Related]
16. Inhibin subunit gene expression in ovarian cancer.
Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
[TBL] [Abstract][Full Text] [Related]
17. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
[TBL] [Abstract][Full Text] [Related]
18. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
19. Beta A versus beta B: is it merely a matter of expression?
Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
[TBL] [Abstract][Full Text] [Related]
20. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
